Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Terminated 4Recruiting 4Completed 3Withdrawn 2Not yet recruiting 2Active not recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Genitourinary 3Endocrine 1

Conditions

Carcinoma, Renal Cell 3Urologic Neoplasms 1Urinary Bladder Neoplasms 1Adrenal Gland Neoplasms 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Nephrectomy × Clear all
NCT00930033 2025-09-05

CARMENA

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
452 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT03473730 2025-01-30

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
17 enrolled
Genitourinary

Carcinoma, Renal Cell, Urologic Neoplasms

NCT04570176 2022-02-16

Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System

The Affiliated Hospital of Qingdao University

Phase NA Completed
1 enrolled
EndocrineGenitourinary

Adrenal Gland Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡